SEARCH

SEARCH BY CITATION

References

  • 1
    Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2: 53848.
  • 2
    Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 69348.
  • 3
    Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 2000; 97: 525560.
  • 4
    Ruf W, Dorfleutner A, Riewald M. Specificity of coagulation factor signaling. J Thromb Haemost 2003; 1: 1495503.
  • 5
    Chargaff E. The isolation of preparations of thromboplastic protein from human organ. J Biol Chem 1945; 161: 38994.
  • 6
    Williams WJ. The activity of human placenta microsomes and brain particles in blood coagulation. J Biol Chem 1966; 241: 18406.
  • 7
    Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59: 42137.
  • 8
    Kuczyński J, Uszyński W, Zekanowska E, Soszka T, Uszyński M. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium. Eur J Obstet Gynecol Reprod Biol 2002; 105: 1519.
  • 9
    Hong JW, Lee WJ, Hahn SB, Kim BJ, Lew DH. The effect of human placenta extract in a wound healing model. Ann Plast Surg 2010; 65: 96100.
  • 10
    Wu CH, Chang GY, Chang WC, Hsu CT, Chen RS. Wound healing effects of porcine placental extracts on rats with thermal injury. Br J Dermatol 2003; 148: 23645.
  • 11
    Grossman N, Binyamin LA, Bodner L. Effect of rat salivary glands extracts on the proliferation of cultured skin cells: a wound healing model. Cell Tissue Bank 2004; 5: 20512.
  • 12
    Noun-Eldin F, Wilkinson JF. The blood clotting factors in human saliva. J Physiol 1957; 136: 32432.
  • 13
    Butzow R, Virtanen I, Seppälä M, Närvänen O, Stenman UH, Ristimäki A, Bohn H. Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry. J Lab Clin Med 1988; 111: 24956.
  • 14
    Udagawa K, Yasumitsu H, Esaki M, Sawada H, Nagashima Y, Aoki I, Jin M, Miyagi E, Nakazawa T, Hirahara F, Miyazaki K, Miyagi Y. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts. Placenta 2002; 23: 14553.
  • 15
    Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G, Ploplis V, Muller M, Nagy A, Plow E, Gerard R, Edgington T, Risau W, Collen D. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann N Y Acad Sci 1997; 811: 191206.
  • 16
    Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, Casper K, Dillehay DL, Nawroth PP, Rickles FR. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 1999; 96: 86638.
  • 17
    Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3: 37984.
  • 18
    Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 735.
  • 19
    Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88: 15837.
  • 20
    Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmbäck K, Danton MJ, Colbert MC, Witte DP, Fujikawa K, Davie EW, Degen JL. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93: 625863.
  • 21
    Erlich J, Parry GC, Fearns C, Muller M, Carmeliet P, Luther T, Mackman N. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci USA 1999; 96: 813843.
  • 22
    Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 6779.
  • 23
    Carson SD, Henry WM, Shows TB. Tissue factor gene localized to human chromosome 1 (lpter–1p21). Science 1985; 229: 9913.
  • 24
    Luther T, Flössel C, Mackman N, Bierhaus A, Kasper M, Albrecht S, Sage EH, Iruela-Arispe L, Grossmann H, Ströhlein A, Zhang Y, Nawroth PP, Carmeliet P, Loskutoff DJ, Müller M. Tissue factor expression during human and mouse development. Am J Pathol 1996; 149: 10113.
  • 25
    Krikun G, Lockwood CJ, Paidas MJ. Tissue factor and the endometrium: from physiology to pathology. Thromb Res 2009; 124: 3936.
  • 26
    Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, Taylor HS, Toti P, Arcuri F, Konigsberg W, Garen A, Booth CJ, Lockwood CJ. The immunoconjugate ‘icon’ targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol 2010; 176: 10506.
  • 27
    Erez O, Romero R, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Chaiworapongsa T, Gotsch F, Fareed J, Hoppensteadt D, Than NG, Yoon BH, Edwin S, Dong Z, Espinoza J, Mazor M, Hassan SS. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor. J Matern Fetal Neonatal Med 2010; 23: 2333.
  • 28
    Erez O, Gotsch F, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, Kim CJ, Chaiworapongsa T, Hoppensteadt D, Fareed J, Than NG, Nhan-Chang CL, Yeo L, Pacora P, Mazor M, Hassan SS, Mittal P, Romero R. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med 2009; 22: 67287.
  • 29
    Erez O, Romero R, Hoppensteadt D, Than NG, Fareed J, Mazaki-Tovi S, Espinoza J, Chaiworapongsa T, Kim SS, Yoon BH, Hassan SS, Gotsch F, Friel L, Vaisbuch E, Kusanovic JP. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med 2008; 21: 85569.
  • 30
    Bellart J, Gilabert R, Angles A, Piera V, Miralles RM, Monasterio J, Cabero L. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 5947.
  • 31
    Di Paolo S, Volpe P, Grandaliano G, Stallone G, Schena A, Greco P, Resta L, Selvaggi L, Cincione R, Schena FP, Gesualdo L. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 2003; 16: 6507.
  • 32
    Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N, Girardi G. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody-induced fetal injury. Blood 2007; 110: 242331.
  • 33
    Redecha P, van Rooijen N, Torry D, Girardi G. Role of tissue factor in placental and fetal injury: pravastatin prevents miscarriages in mice. Blood 2009; 113: 41019.
  • 34
    Redecha P, Franzke C, Ruf W, Mackman N, Girardi G. Activation of neutrophils by the tissue factor–factor VIIa–PAR-2 axis mediates fetal death in antiphospholipid syndrome. J Clin Invest 2008; 118: 345361.
  • 35
    Giesen PL, Rauch U, Bohrmann B, Kling D, Roqué M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 231115.
  • 36
    Østerud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost 2006; 32: 1123.
  • 37
    Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 2006; 177: 4794802.
  • 38
    Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78: 74754.
  • 39
    Taylor FB, Chang AC, Esmon CT, Hinshaw LB. Baboon model of Escherichia coli sepsis: description of its four stages and the role of tumor necrosis factor, tissue factors, and the protein C system in septic shock. Curr Stud Hematol Blood Transfus 1991; 58: 814.
  • 40
    Tremoli E, Camera M, Toschi V, Colli S. Tissue factor in atherosclerosis. Atherosclerosis 1999; 144: 27383.
  • 41
    Wakita Y, Wada H, Nakase T, Nakasaki T, Shimura M, Hiyoyama K, Mori Y, Gabazza EC, Nishikawa M, Deguchi K, Shiku H. Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant. Clin Appl Thromb Hemost 1999; 5: 1015.
  • 42
    Weinberg JB, Wortham TS, Misukonis MA, Patton KL, Chitneni S. Synovial mononuclear phagocytes in rheumatoid arthritis and osteoarthritis: quantitative and functional aspects. Immunol Invest 1993; 22: 36574.
  • 43
    Cunningham MA, Kitching AR, Tipping PG, Holdsworth SR. Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis. Kidney Int 2004; 66: 64754.
  • 44
    Zhou H, Wolberg AS, Roubey RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004; 104: 23538.
  • 45
    Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody induced fetal loss by inhibiting complement activation. Nat Med 2004; 10: 12226.
  • 46
    Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, Lambris JD, Holers VM, Salmon JE. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 164454.
  • 47
    Egorina EM, Sovershaev MA, Olsen JO, Osterud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 2008, 111: 120816.
  • 48
    Bunnett NW. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost 2006; 32: 3948.
  • 49
    Chin AC, Lee WY, Nusrat A, Vergnolle N, Parkos CA. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J Immunol 2008; 181: 570210.
  • 50
    Shpacovitch VM, Seeliger S, Huber-Lang M, Balkow S, Feld M, Hollenberg MD, Sarma VJ, Ward PA, Strey A, Gerke V, Sommerhoff CP, Vergnolle N, Steinhoff M. Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol 2007; 16: 799806.
  • 51
    Ahamed J, Niessen F, Kurokawa T, Lee YK, Bhattacharjee G, Morrissey JH, Ruf W. Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. Blood 2007; 109: 52519.
  • 52
    Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon J. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006; 203: 216575.